The Selective mGlu4 Receptor Agonist LSP1-2111 is not Transformed Into L-AP4 Under Alkaline pH Conditions

被引：0
|
作者：
Pedersen, H. [1 ]
Huang, X. [2 ]
Acher, F. [2 ]
Doller, D. [3 ]
机构：
[1] HS Lundbeck, Discovery Chem & DMPK, Valby, Denmark
[2] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, F-75270 Paris 06, France
[3] Lundbeck Res USA, Discovery Chem & DMPK, Paramus, NJ USA
来源：
CURRENT NEUROPHARMACOLOGY | 2014年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
131
引用
收藏
页码：50 / 51
页数：2
相关论文
共 22 条
  • [1] The involvement of mGlu4, yet not the mGlu7 Receptor, in the Potential Antipsychotic-Like Action of mGlu Group III Receptor Ligands: Focusing on LSP1-2111 and AMN082 Activity
    Wieronska, J. M.
    Stachowicz, K.
    Branski, P.
    Palucha-Poniewiera, A.
    Lech, T.
    Acher, F. C.
    Pilc, A.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 66 - 66
  • [2] Pro-depressive-like effects of mGlu4 selective agonist LSP4-2022 in mice
    Rzezniczek, S.
    Podkowa, K.
    Marciniak, M.
    Acher, F.
    Pilc, A.
    Palucha-Poniewiera, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S379 - S379
  • [3] the Effect of mGlu4 Selective Agonist, LSP-42022 on the Immobility Time in the TST and in the FST in Mice
    Palucha-Poniewiera, A.
    Marciniak, M.
    Podkowa, K.
    Acher, F.
    Pilc, A.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 50 - 50
  • [4] A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action
    Podkowa, Karolina
    Rzezniczek, Szymon
    Marciniak, Marcin
    Acher, Francine
    Pilc, Andrzej
    Palucha-Poniewiera, Agnieszka
    NEUROPHARMACOLOGY, 2015, 97 : 338 - 345
  • [5] Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022
    Wozniak, Monika
    Golembiowska, Krystyna
    Noworyta-Sokolowska, Karolina
    Acher, Francine
    Cieslik, Paulina
    Kusek, Magdalena
    Tokarski, Krzysztof
    Pilc, Andrzej
    Wieronska, Joanna M.
    NEUROPHARMACOLOGY, 2017, 115 : 149 - 165
  • [6] Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems
    Wieronska, Joanna M.
    Stachowicz, Katarzyna
    Palucha-Poniewiera, Agnieszka
    Acher, Francine
    Branski, Piotr
    Pilc, Andrzej
    NEUROPHARMACOLOGY, 2010, 59 (7-8) : 627 - 634
  • [7] Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022
    Wozniak, Monika
    Acher, Francine
    Marciniak, Marcin
    Lason-Tyburkiewicz, Magdalena
    Gruca, Piotr
    Papp, Mariusz
    Pilc, Andrzej
    Wieronska, Joanna M.
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (05) : 413 - 426
  • [8] LSP2-9166, an orthosteric mGlu4 and mGlu7 receptor agonist, reduces cocaine self-administration under a progressive ratio schedule in rats
    Nogueira, David De Sa
    Bourdy, Romain
    Filliol, Dominique
    Quessada, Cyril
    McCort-Tranchepain, Isabelle
    Acher, Francine
    Zwiller, Jean
    Romieu, Pascal
    Befort, Katia
    NEUROSCIENCE LETTERS, 2021, 764
  • [9] Determination of L-AP4-bound human mGlu8 receptor amino terminal domain structure and the molecular basis for L-AP4's group III mGlu receptor functional potency and selectivity
    Schkeryantz, Jeffery M.
    Chen, Qi
    Ho, Joseph D.
    Atwell, Shane
    Zhang, Aiping
    Vargas, Michelle C.
    Wang, Jing
    Monn, James A.
    Hao, Junliang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 612 - 617
  • [10] LSP1-2111, a new orthosteric group III mGlur agonist with preferential activity on mGluR4, modulates the striatopallidal synapse and alleviates parkinsonian symptoms
    Beurrier, C.
    Revy, D.
    Lopez, S.
    Lherondel, M.
    Goudet, C.
    Acher, F.
    Amalric, M.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 587 - 588
123